Table of contents

Original Article

• Gene expression in epithelial ovarian cancer: a study of intratumor heterogeneity (1 September, 2007)

  K. M. Jochumsen, Q. Tan, B. HØLUND, T. A. Kruse, O. Mogensen
• Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancer (1 September, 2007)

  M. O. Nicoletto, S. Tumolo, R. Sorio, G. Cima, L. Endrizzi, O. Nascimben, O. Vinante, G. Artioli, M. Donach, G. Cartei
• The evaluation of intra- and postoperative complications related to debulking surgery with bowel resection in patients with FIGO stage III–IV ovarian cancer (1 September, 2007)

  M. Bidzinski, P. Derlatka, P. Kubik, I. Ziolkowska-Seta, A. Dańska-Bidzinska, L. Gmyrek, P. Sobiczewski, G. Panek
• Outcomes for patients with fallopian tube carcinoma managed with adjuvant chemotherapy following primary surgery: a retrospective university experience (1 September, 2007)

  C. A. Leath, T. M. Numnum, J. M. Straughn, R. P. Rocconi, W. K. Huh, L. C. Kilgore, E. E. Partridge
• Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience (1 September, 2007)

  D. Pectasides, G. Fountzilas, G. Aravantinos, A. Bamias, H. P. Kalofonos, D. Skarlos, E. Briasoulis, A. Konstantara, Th. Economopoulos, M. A. Dimopoulos
• Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature (1 September, 2007)

  A. Auranen, J. Sundström, J. Ijäs, S. Grénman
• Pegfilgrastim for the prevention of febrile neutropenia in patients with epithelial ovarian carcinoma—a cost-effectiveness analysis (1 September, 2007)

  T. M. Numnum, K. J. Kimball, R. P. Rocconi, L. C. Kilgore, J. M. Straughn
• The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy (1 September, 2007)

  R. Athavale, N. Thomakos, K. Godfrey, F. Kew, P. Cross, A. De Barros Lopes, M. H. Hatem, R. Naik
• Discrepancy between magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography imaging in a case of borderline ovarian tumor (1 September, 2007)

  W. Ju, S. C. Kim
• Importance of a specialized pathologist for the examination of frozen sections of adnexal masses (1 September, 2007)

  F. Fanfani, G. F. Zannoni, A. Fagotti, M. L. Gagliardi, V. Masciullo, A. C. Testa, G. Scambia
• Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary (1 September, 2007)

  T. Oishi, H. Itamochi, J. Kigawa, Y. Kanamori, M. Shimada, M. Takahashi, R. Shimogai, W. Kawaguchi, S. Sato, N. Terakawa
• Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow (1 September, 2007)

  C Schindlbeck, P Hantschmann, M Zerzer, B Jahns, D Rjosk, W Janni, B Rack, H Sommer, K Friese
• Results of chemotherapy for pulmonary metastases of carcinoma of the cervix in patients after primary surgical and radiotherapeutic management (1 September, 2007)

  G. Panek, K. Gawrychowski, P. Sobiczewski, P. Derlatka, A. Danska-Bidzinska, L. Gmyrek, M. Bidzinski
• The prognostic value of pretreatment 2-(¹⁸F)-fluoro-2-deoxy-D-glucose positron emission tomography scan in women with cervical cancer

  (1 September, 2007)

  J. B. Unger, D. L. Lilien, G. Caldito, J. J Ivy, A. Charrier, B. Bellaire
• Circulating neutrophils may play a role in the host response in cervical cancer (1 September, 2007)

  P. C. Fernandes, C. B. Garcia, D. C. Micheli, F. Q. Cunha, E. F.C. Murta, B. M. Tavares-Murta
• A case-controlled study of total laparoscopic radical hysterectomy with pelvic lymphadenectomy versus radical abdominal hysterectomy in a fellowship training program (1 September, 2007)

  K. Zakashansky, L. Chuang, H. Gretz, N. P. Nagarsheth, J. Rahaman, F. R. Nezhat
• An oligoarray for the detection of human papillomavirus type 16 variants (1 September, 2007)

  P. Mendoza-Lorenzo, R. Maldonado, R. Pacheco, A. MÉNDEZ, P. Piña-Sánchez, A. Rangel, G. Vazquez-Ortíz, M. Salcedo
• Transcriptional expression of survivin and its splice variants in cervical carcinomas (1 September, 2007)

  H. Futakuchi, M. Ueda, K. Kanda, K. Fujino, H. Yamaguchi, S. Noda
• p16^INK4a Expression does not predict the outcome of cervical intraepithelial neoplasia grade 2

  (1 September, 2007)

  A. C. Guedes, S. M.F. Brenna, S. A.S. Coelho, E. Z. Martinez, K. J. Syrjänen, L. C. Zeferino
• Sexual dysfunction in Thai women with early-stage cervical cancer after radical hysterectomy (1 September, 2007)

  S. Tangjitgamol, S. Manusirivithaya, J. Hanprasertpong, P. Kasemsarn, T. Soonthornthum, S. Leelahakorn, T. Thawaramara, O. Lapcharoen
• Sentinel lymph node in endometrial cancer (1 September, 2007)

  L.A.F Lopes, S. M Nicolau, F. F Baracat, E. C Baracat, W. J Gonçalves, H.V.B Santos, R. G Lopes, U. G Lippi
• The relation between age, time since menopause, and endometrial cancer in women with postmenopausal bleeding (1 September, 2007)

  H. C. Van Doorn, B. C. Opmeer, M. Jitze Duk, R. F.M.P. Kruitwagen, F. P.H.L.J. Dijkhuizen, B. W. Mol
• Dynamic staging and risk factor scoring for gestational trophoblastic disease (1 September, 2007)

  E. I. Kohorn